Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.6 USD | +0.14% | -0.53% | +7.75% |
06-13 | AbbVie inks immune disorder drug licensing deal with China's FutureGen | RE |
06-13 | AbbVie, FutureGen in License Pact for Inflammatory Bowel Disease Drug | DJ |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
795B | ||||||
350B | - | - | - | - | ||
328B | ||||||
245B | ||||||
222B |